Summary
- Current Price
- As of today, NVCR price is $14.42, down -1.77% in the most recent trading session on
- Current Price All-Time High
- NVCR price is currently -93.80% below its historical high of $232.76 set on
- Market Cap
- NVCR current market cap is $2B, up +9.06% over the past 365 days
- Revenue
- NVCR current annual revenue is $655.35M, up +8.28% year-over-year
- Next Earnings
- The next earnings release for NVCR is on
Profile
| Metric | Value |
|---|---|
| Full Name | NovoCure Limited |
| Ticker | NASDAQ: NVCR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | novocure.com |
| Employees | 1,488 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $14.42 | |
| Price, 1D Change | -1.77% | |
| $2B | ||
| - | ||
| - | ||
| 1.55 | ||
| $655.35M | ||
| Revenue, 1Y Change | +8.28% | |
| -$1.22 | ||
| EPS, 1Y Change | +21.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.22 | ||
| EPS Estimate | -$1.24 | N/A |
| EPS Est. Change | -1.06% | N/A |
| $655.35M | ||
| Revenue Estimate | $726.12M | N/A |
| Revenue Est. Change | +10.80% | N/A |
| Current Price | $14.42 | |
| Price Target | $23.00 | - |
| Price Tgt. Change | +59.50% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.30 | -$1.56 | -20.63% | |
| -$1.40 | -$1.22 | +12.79% | |
| -$1.24 | N/A | -1.06% | |
| -$0.81 | N/A | +34.02% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $605.24M | $605.22M | -0.00% | |
| $654.42M | $655.35M | +0.14% | |
| $726.12M | N/A | +10.80% | |
| $804.78M | N/A | +22.80% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $14.42 | |
| $14.82 | ||
| $16.15 | ||
| $15.41 | ||
| $15.68 | ||
| -$0.32 | ||
| 1.55 | ||
| $0.70 | ||
| 44.22 | ||
| 58.99% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $655.35M | ||
| -$1.22 | ||
| $0.00 | ||
| 74.80% | ||
| -$152.09M | ||
| -23.21% | ||
| -$136.23M | ||
| -20.79% | ||
| -$137.44M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.73 | ||
| 2.90 | ||
| 2.71 | ||
| - | ||
| 4 | ||
| 1.37 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 2.40 | ||
| 4.97 | ||
| -10.59 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $340.47M | ||
| $457.52M | ||
| $804.33M | ||
| $646.73M | ||
| $463.86M | ||
| $223.23M | ||
| $248.35M | ||
| $11.66M | ||
| $122.23M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $791.58M | ||
| $642.27M | ||
| $165.17M | ||
| $417.73M | ||
| $14.65M | ||
| $0.00 | ||
| -$23.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$49.03M | ||
| $437.28M | ||
| -$451.34M | ||
| $26.65M | ||
| -$75.68M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| Evercore ISI Group | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NVCR
FAQ
- What is the ticker symbol for NovoCure Limited?
- The ticker symbol for NovoCure Limited is NASDAQ:NVCR
- Does NovoCure Limited pay dividends?
- No, NovoCure Limited does not pay dividends
- What sector is NovoCure Limited in?
- NovoCure Limited is in the Healthcare sector
- What industry is NovoCure Limited in?
- NovoCure Limited is in the Medical Devices industry
- What country is NovoCure Limited based in?
- NovoCure Limited is headquartered in Switzerland
- When did NovoCure Limited go public?
- NovoCure Limited initial public offering (IPO) was on October 2, 2015
- Is NovoCure Limited in the S&P 500?
- No, NovoCure Limited is not included in the S&P 500 index
- Is NovoCure Limited in the NASDAQ 100?
- No, NovoCure Limited is not included in the NASDAQ 100 index
- Is NovoCure Limited in the Dow Jones?
- No, NovoCure Limited is not included in the Dow Jones index
- When was NovoCure Limited last earnings report?
- NovoCure Limited's most recent earnings report was on July 23, 2026
- When does NovoCure Limited report earnings?
- The next expected earnings date for NovoCure Limited is October 29, 2026
Data Sources & References
- NVCR Official Website www.novocure.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm
- NVCR Profile on Yahoo Finance finance.yahoo.com/quote/NVCR
- NVCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvcr